Today, Cipralex® (escitalopram) has been approved in the EU for the treatment of obsessive compulsive disorder (OCD) by the Swedish Medical Products Agency (MPA) acting as reference member state for the European Union (EU). The approval is based on clinical studies involving more than 750 patients, which demonstrate that Cipralex® is an effective and well-tolerated drug in the treatment of OCD with the added benefit of significantly reducing the risk of relapse in OCD patients.
H. Lundbeck, Cipralex® approved for the treatment of obsessive compulsive disorder (OCD)
| Source: H. Lundbeck A/S
Attachments
